EMEA-001990-PIP01-16-M05
Key facts
Active substance |
Fenfluramine hydrochloride
|
Therapeutic area |
Neurology
|
Decision number |
P/0390/2022
|
PIP number |
EMEA-001990-PIP01-16-M05
|
Pharmaceutical form(s) |
Oral solution
|
Condition(s) / indication(s) |
Treatment of Dravet syndrome
|
Route(s) of administration |
|
Contact for public enquiries |
Zogenix International Ltd
Email: medinfo.eu@zogenix.com |
Decision type |
PM: decision on the application for modification of an agreed PIP
|